The FDA defines Class I recalls as, “a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.”
Teleflex is recalling the products due to complaints it has received that the ends of the pediatric breathing circuits can crack before and during use. There have been no reports of patient injury as a result of this issue.
More articles on anesthesia:
Blue Cross Blue Shield of Michigan launches anesthesiology improvement collaborative
Should anesthesiologists worry about computers taking their jobs?
Sheridan Healthcare’s Dr. Adam Blomberg presents at ACHE Chapter Panel
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.